Summary: A study published in PLOS One (a peer reviewed journal from the Public Library of Science) concludes that THC concentrations in most marijuana being sold in the U.S. for neuropathic pain render it too potent to be effective. The study found no clinical differences between "recreational" and "medical" marijuana. Other studies have shown that THC is not effective in treating chronic pain other than neuropathic. Authors of the study make specific recommendations to policy makers in states with "medical" marijuana, including the recommendation to limit the THC potency on marijuana products to 10% or less.
By Colton Grace
Published by Smart Approaches to Marijuana (SAM)
Comments